Last reviewed · How we verify
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Study to Determine the Efficacy of Montelukast in the Treatment of Exacerbations in Asthmatic Patients Aged 2-to-5 Years
A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.
Details
| Lead sponsor | Organon and Co |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 500 |
| Start date | 2001-01 |
| Completion | 2002-12 |
Conditions
- Asthma
Interventions
- montelukast
- placebo (unspecified)
Primary outcomes
- asthma episodes in 2 - 5 year old children — at 12 months